Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain
about
Role of central dopamine in pain and analgesiaSEP-225289 serotonin and dopamine transporter occupancy: a PET studyTriple reuptake inhibitors: the next generation of antidepressantsTriple Reuptake Inhibitors: A Premise and PromiseThe effect of food deprivation on nociception in formalin test and plasma levels of noradrenaline and corticosterone in rats.The secrets of a successful clinical trial: compliance, compliance, and compliance.Preclinical evaluation of the abuse potential of the analgesic bicifadine.The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study.Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in ratsTriple reuptake inhibitors as potential next-generation antidepressants: a new hope?Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.Triple reuptake inhibitors: a patent review (2006 - 2012).An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.Biotransformation and bioactivation reactions of alicyclic amines in drug molecules.Expert opinion on emerging drugs: chronic low back pain.Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model.Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs).
P2860
Q22241489-6E091BFF-2D0B-47C4-9A4A-BAB2E396246EQ24631062-D526602A-39DF-4B38-BC18-FD152ED73505Q24658248-FF2EEAC5-E369-47F5-BB23-B943C36A9225Q28972234-0283F010-BA43-44FB-BEFA-4C4666007496Q34368104-71E8AF29-B7C2-4154-88C9-F5E1A853041FQ35030320-CA84E98F-4455-474A-8E7F-0EE331F79A71Q35453895-FF9BB556-D778-4BF6-968F-685A5E786CFEQ35541620-CA8415AD-15FF-46B4-A73F-C5E400C78764Q37095221-D52389AE-4949-4783-AD31-41C9318A70EEQ37158450-391740EF-193D-45D4-B579-4BF65464FB0CQ37891098-71792697-9EDB-4D6E-AB49-C92698C482EDQ38167327-FC8B1A48-8066-44C3-AE61-68946B5BD816Q38167857-7ED4F272-5056-4B06-B13B-5EFB68E4D914Q38218540-9095A9B0-8DAF-4825-BD48-8B38D6D9C1A9Q38292223-7E1ABFC3-6E22-49A7-A5A1-CC5D747744D8Q45840756-722C5FAA-922B-4636-A1EE-3ECC9D05D533Q48250330-63F279F3-5B5B-4561-A578-3F236DD6E3A9Q55421497-14352244-793A-4561-931B-0B7BA19069B3
P2860
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Characterization of the antino ...... , persistent, and chronic pain
@ast
Characterization of the antino ...... , persistent, and chronic pain
@en
Characterization of the antino ...... , persistent, and chronic pain
@nl
type
label
Characterization of the antino ...... , persistent, and chronic pain
@ast
Characterization of the antino ...... , persistent, and chronic pain
@en
Characterization of the antino ...... , persistent, and chronic pain
@nl
prefLabel
Characterization of the antino ...... , persistent, and chronic pain
@ast
Characterization of the antino ...... , persistent, and chronic pain
@en
Characterization of the antino ...... , persistent, and chronic pain
@nl
P2093
P50
P356
P1476
Characterization of the antino ...... , persistent, and chronic pain
@en
P2093
Aaron Janowsky
Anthony S Basile
Arnold S Lippa
Elena Koustova
Magdalena Kowalska
Morris Benveniste
Phil Skolnick
Philip A Krieter
P304
P356
10.1124/JPET.106.116483
P407
P577
2007-06-01T00:00:00Z